Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

NexMed completes dosing in two-year rat carcinogenicity study

Jan. 7, 2003

License agreement for Befar in South Korea

Dec. 30, 2002

Two pivotal phase III trials of Alprox-TD completed

Dec. 18, 2002

RenaZorb begins testing in animals

Dec. 12, 2002

European approval for Avodart for benign prostatic hyperplasia

Dec. 11, 2002

Lilly and Boehringer Ingelheim sign cocommercialization agreements for duloxetine

Dec. 10, 2002

Lilly Icos presents new PDE5 inhibitors for male and female sexual dysfunction

Dec. 9, 2002

Marketing authorization application submitted for Striant in U.K.

Dec. 9, 2002

ZP-120 completes phase I trial

Dec. 9, 2002

Kissei licenses KUC-7483 to Boehringer Ingelheim

Dec. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...